Innovation: understanding the real business challenges in 2026

Four decisions structure the project: the legal form and the director's social security status (SASU or EURL), the tax regime, VAT and first-year business property tax. Consulting work does not qualify for the research tax credit, which covers research and experimental development only, but a provider can apply for approval from the ministry in charge of research.

Innovation is not only about technology, R&D or digital transformation. In a company, it also touches the organisation, the product and service offering, the operating processes, customer relationships, margins and the ability to remain competitive over time. In 2026, French businesses face simultaneous pressures: digital transition, environmental requirements, skills shortages and the acceleration of artificial intelligence. In this context, innovation becomes as much a matter of survival as of growth.

Between 2020 and 2022, 46% of French companies with 10 or more employees in the non-agricultural market sectors innovated: 39% in processes (including organisation and marketing) and 19% in products, against 47% over 2018-2020 (INSEE, CIS 2022 survey). One innovative company in three reports having lacked the resources to innovate further. The gap is not due to a lack of ideas. It comes down to how innovation is steered, funded and connected to overall strategy.

The businesses that extract the most value from innovation are not necessarily those that innovate the most: they are those that manage innovation like a real business project, with clear criteria, structured funding and measurable outcomes.

A company can innovate along several dimensions simultaneously, and management teams sometimes underestimate the full scope:

• by the offer: new products, new services, new variants or evolutions of the existing range that open new market segments or better meet the needs of existing customers;
• by the processes: operating method changes that reduce waste, reduce cycle time, improve quality consistency or lower the cost base;
• by the distribution channels: reaching customers differently, through digital, through new partnerships, through new geographies, without necessarily changing the core product;
• by the business model: changing how value is captured, moving from one-time sales to recurring revenue, from products to services, from direct to platform models.

Organisational innovation is often the most neglected. Reorganising a team, automating an administrative process or rethinking the decision chain is nonetheless innovation in its own right, and is counted as such in official statistics.

For a management team, innovation raises very concrete questions that go well beyond R&D decisions:

• how to prioritise projects: which innovation initiatives deserve internal investment and management attention, and which can wait or be deprioritised without affecting competitive position?
• how to finance experimentation: innovation involves spending before returns materialise: how to finance the trial phase without undermining short-term profitability or cash position?
• how to protect profitability during the transition: new product launches and process changes consume management bandwidth and operational resources. The risk of disrupting what already works is real;
• how to bring the teams along: organisational changes required by innovation often face internal resistance. Change management is as important as the technical or commercial decision.

In France, the France 2030 plan, endowed with €54 billion, illustrates the scale of public effort in favour of innovation. It is steered by the General Secretariat for Investment and delivered by four operators: Bpifrance, ADEME, ANR and the Caisse des Dépôts. But on the company side, the challenge remains resource allocation: too many scattered projects, not enough concentration on the highest-impact initiatives.

France's innovation funding ecosystem is one of the most comprehensive in Europe. Companies do not lack tools. They often lack visibility on which ones genuinely match their situation.

The main levers include:

• the Research Tax Credit (CIR): 30% of eligible expenditure up to €100 million and 5% above that threshold (50% in the French overseas departments). For 2023, 23,526 companies benefited from it, for a total claim of €7.85 billion; SMEs make up 81% of research-CIR beneficiaries but take only 31% of the credit (MESR-DGRI, provisional data);
• the Young Innovative Company (JEI) status: this grants a full exemption from employer social-security and family allowance contributions on staff assigned to R&D, until the last day of the 7th calendar year following the year of incorporation, within a cap of EUR 8,401.58 of gross monthly pay per employee and EUR 240,300 per establishment per year. Subject to a decision by the local authority, it also grants a 7-year exemption from CFE (business property tax) and property tax for companies created before 31 December 2028, conditional on a prior filing with the business tax office before 1 January of the year concerned, plus an income tax reduction for investors subscribing to the company's capital. By contrast, the corporate income tax exemption was abolished for companies incorporated on or after 1 January 2024: it survives only for those incorporated up to 31 December 2023.

It is open to EU-definition SMEs less than eight years old (an age condition applying to companies created from 1 January 2023), at least 50% of whose capital is held by individuals or public or scientific bodies, and whose R&D spend reaches at least 20% of their tax-deductible expenses;

• Bpifrance support: innovation loans, grants, guarantees and equity participation. Bpifrance intervenes at every stage of the lifecycle, from seed funding to industrial deployment;
• regional and European aid: each region has its own mechanisms, often unknown to very small and medium-sized enterprises.

European programmes such as Horizon Europe also offer co-funding opportunities;

• crowdfunding and venture capital: they complement public schemes on capital-intensive projects.

The question is therefore not "is there funding available?" but "what combination of mechanisms maximises the return on every euro invested in innovation?"

Many innovation projects start with a company to incorporate: a consulting firm, an engineering office, a specialist practice. Four decisions then arise, in this order.

Legal form and the director's social security status. In a SASU, the sole shareholder sets the share capital freely, from €1. The president is treated as an employee for social security purposes as soon as he or she is paid for the office held: cover falls under the general scheme, with the social protection of a salaried executive, except for unemployment insurance, to which no contribution is paid. In an EURL, a managing director who is also the sole shareholder falls under the self-employed scheme, with contributions based on professional income, whereas a non-shareholder manager is treated as an employee. It is this social security point, more than tax, that separates the two forms most clearly for a consultant starting out alone.

Tax regime. In a SASU, the default regime is corporate income tax at 25%, with a reduced rate of 15% on the first €42,500 of profit for qualifying SMEs. An option for personal income tax is available for five non-renewable financial years, restricted to companies with fewer than 50 employees, less than €10 million of revenue or total assets, and incorporated less than five years ago. In a SASU, dividends are not remuneration and bear no social security contributions.

VAT. Consulting services fall within the VAT franchise regime as long as prior-year revenue stays below €37,500, with an increased threshold of €41,250 during the year. Under the franchise, invoices carry the wording "TVA non applicable, article 293 B du CGI", input VAT is not deductible and the company is exempt from VAT returns. Crossing the base threshold makes the company liable from the following 1 January; crossing the increased threshold makes it liable from the first day of the overrun.

First-year CFE. The company is fully exempt from the business property tax (CFE) until 31 December of the year in which the activity starts, provided the initial 1447-C-SD return is filed before 31 December. Its taxable base is then halved the following year, and afterwards set on a minimum base depending on revenue earned two years earlier and on the municipality (articles 1447 and 1647 D of the French tax code).

What consulting work does not give access to#

This deserves to be stated plainly: consulting work does not qualify for the research tax credit. Only fundamental research, applied research and experimental development are eligible, defined by reference to the OECD Frascati Manual. The tax authorities require five cumulative criteria: an element of novelty, creativity, scientific or technical uncertainty to be resolved, a systematic approach, and transferability or reproducibility of results. Work that draws on the existing state of the art without resolving uncertainty is engineering and is expressly excluded from the credit.

The real lever for an innovation consulting firm lies elsewhere: approval. For the R&D spending a client entrusts to it to be included in that client's research tax credit, the provider must be approved by the ministry in charge of research. Without approval, that spending is excluded from the client's calculation. Private companies, individual experts, design offices and stylists, scientific foundations and research bodies established in France, in the European Union or in the European Economic Area are all concerned. Applications are filed through the CIROCO portal; approval is granted for three years, reduced to one year where no R&D operation has been carried out in the previous twelve months, and it can reach five years after the third renewal. For an innovation consulting firm this is a decisive commercial argument: without approval it is structurally less attractive than an approved competitor.

Structure and access to the schemes are framed together: see innovation funding through the CIR, the CII and the JEI status and company formation in Paris.

While companies often focus on technological innovation, organisational innovation tends to take second place. It covers:

• team reorganisation to encourage cross-functional collaboration and rapid decision-making;
• automation of repetitive processes: accounting, reporting, administrative management, customer relations;
• implementing agile methods beyond IT teams, in marketing, operations and human resources;
• creating feedback loops between the field and management so that decisions are based on real data rather than intuition.

The companies that innovate most effectively are generally those that combine product innovation and organisational innovation. One without the other eventually creates imbalances: an excellent product poorly served by slow processes, or a modern organisation with nothing new to sell.

No innovation holds without the skills to drive it. In 2026, the talent shortage in digital, data and artificial intelligence remains a major barrier for French SMEs. Several approaches can help overcome this difficulty:

• continuous training: investing in upskilling existing teams, often less costly than recruitment;
• targeted recruitment: identifying hybrid profiles capable of bridging the gap between technical and business functions;
• using external experts: consultants, outsourced CFOs, advisory firms to bring in specific skills without increasing the payroll burden;
• academic partnerships: collaborating with schools, universities or research laboratories to access cutting-edge expertise and dedicated funding.

Retaining innovative talent is equally critical. Competent employees in emerging fields are constantly solicited. Offering them a stimulating environment, autonomy and a clear vision is often more decisive than salary level alone.

One of the major challenges of innovation is measuring its impact. Unlike a conventional investment, the return on an innovation project is often uncertain, diffuse and delayed. Several indicators nevertheless allow performance to be tracked:

1. the ratio of innovation expenditure to revenue: a simple indicator to gauge innovation effort relative to company size. It is read over time and compared with peers in the same sector, rather than against a general benchmark;
2. the share of revenue from products or services less than three years old: this measures the capacity to renew the offering;
3. time to market: the time elapsed between the initial idea and effective commercialisation.

A reducing timeline is generally a sign of an improving organisation; 4. project success rate: the number of projects reaching maturity relative to the number launched. A rate that is too high may indicate a lack of ambition, while a rate that is too low suggests a selection or execution problem; 5. impact on margin: innovation must, ultimately, improve profitability.

If innovation spending grows without margin impact, the model needs reviewing.

See also research tax credit (CIR), public innovation funding 2026 and how AI can accelerate your business growth in 2026.

Hayot Expertise advice: innovation creates value when it is connected to a logic of prioritisation, funding and economic return. Without that connection, it remains a stated priority rather than a real operational lever. The organisations that get the most out of innovation are those that manage it as an investment portfolio, with selection criteria, validation milestones and clear performance indicators, not just those that talk about it.

Before committing resources to an innovation project, four dimensions deserve to be framed:

1. the economic objective of each project: what specific metric does this innovation improve (revenue, margin, customer retention, cost per unit) and by how much?
2. the human and financial resources committed: is the allocation of resources proportional to the expected return and the risk involved?
3. the support schemes and tax regimes available: are the CIR, JEI status, Bpifrance funding, ADEME support and regional mechanisms explored for every eligible project?
4. the ability to scale: can the successful pilot be industrialised at a cost and speed that justifies the initial investment?